RICHARD FRITSCHI JOINS BOARD OF DIRECTORS AT HOCOMA
25th June 2014
At the general meeting on June 19, 2014, Richard Fritschi was elected as a new member of the Hocoma Board of Directors. In his new role, Fritschi supports the Swiss medical technology company with his vast international experience and profound knowledge in the Medtech industry.
Hocoma was set up in 2000, as a spin-off of the Swiss University Hospital Balgrist. The company currently employs more than 160 people at its headquarters near Zurich, Switzerland and at its subsidiaries in the US, Singapore and Slovenia. Hocoma is the global market leader for the development, manufacturing and marketing of robotic and sensorbased devices for functional movement therapy. Therapy solutions support the treatment of neurological patients with movement disorders caused by stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, cerebral palsy or other neurological diseases and injuries as well low back pain patients.The product range features devices for intensive gait therapy (Lokomat®), functional therapy of the upper extremities (Armeo®), early rehabilitation and patient mobilization (Erigo®) as well as functional movement therapy within low back pain treatment (Valedo®) at home and at the therapist’s office. Hocoma’s products are applied successfully in clinics and research institutes worldwide. The medical technology company has received many awards and was honored with the “Red Herring 100 Global Award” in January 2010, as one of the hundred most innovative companies worldwide. Hocoma generated a turnover of more than 30 million CHF in 2013. Dr. Gery Colombo is the CEO of Hocoma AG.